UPL Corporation, a global agrochemical major, delivered a strong set of numbers for the March quarter of FY25, but the stock fell from its intraday highs after the company’s FY26 growth guidance failed to meet investor expectations. While the company’s Q4 EBITDA surged 68% year-on-year, its revenue growth projection for FY26 remained flat compared to FY25, triggering market concerns.

Q4 Performance: Solid Growth Across Segments

In its post-earnings report, UPL reported an 11% rise in quarterly revenue, reaching ₹15,573 crore. This growth was driven by volume expansion and robust performance across its core businesses – crop protection, seeds, and specialty chemicals.

The company’s EBITDA stood at ₹3,240 crore, up 68% from the same quarter last year, supported by efficient operations and higher sales. This impressive performance led to an EBITDA margin improvement, jumping to 20.79% from 13.7% in Q4FY24.

UPL attributed this margin expansion to operational efficiencies, price optimisation, and favourable product mix.

Full Year Snapshot: Growth Fueled by Volumes

For the full financial year FY25, UPL’s revenue growth was largely volume-led, driven by expansion in key segments:

• Crop Protection: Strong demand for herbicides and fungicides in global markets.

• Seeds: Stable growth supported by new product launches.

• Specialty Chemicals: Continued traction in industrial and high-margin categories.

FY26 Guidance Leaves Investors Underwhelmed

Despite the solid FY25 performance, UPL’s guidance for FY26 failed to excite the Street. The company expects:

• Revenue growth between 4% and 8%, same as FY25

• EBITDA growth between 10% and 14%, much lower than the 50% growth achieved in FY25

This lack of acceleration in revenue and sharp moderation in EBITDA guidance has raised questions about near-term demand visibility and margin sustainability in a volatile global agrochemical environment.

Stock Market Reaction: Gains Erased

Following the results announcement, UPL shares initially surged but soon reversed gains due to the muted outlook. As of the latest trade, the stock was down 1.3% at ₹665, after climbing higher earlier in the day.

However, it's worth noting that UPL stock has gained 33% so far in 2025, reflecting strong investor interest ahead of earnings and optimism around the company's turnaround post a challenging FY24.

Significant Debt Reduction Strengthens Balance Sheet

A key highlight of the March quarter was UPL’s success in reducing its net debt, which now stands at ₹8,320 crore, down from ₹13,860 crore in Q4FY24.

This substantial deleveraging was enabled by:

• Operating Free Cash Flow of ₹4,450 crore

• Proceeds from two capital transactions

These efforts significantly strengthen UPL’s balance sheet and offer greater financial flexibility to pursue growth or acquisitions in the future.

Dividend Boost for Shareholders

In a positive move for investors, UPL announced a dividend of ₹6 per share, rewarding shareholders amidst the earnings momentum. This aligns with the company’s strategy to maintain a steady payout ratio while balancing growth and debt reduction.

Investor Concerns and Outlook

While the company’s Q4 and FY25 performance was stellar, the guidance for FY26 has raised some key investor concerns:

• Why is EBITDA growth guidance significantly lower?

• Does the revenue growth plateau signal demand saturation?

• Can debt reduction efforts continue if operating cash flows decline?

However, management remains confident in its long-term strategy, which includes:

• Geographic expansion

• Diversification of product portfolio

• Sustainability and innovation investments

Conclusion

UPL’s fourth-quarter results showcased strong operational performance, robust margin recovery, and effective debt management. But the cautious guidance for FY26 has dampened the sentiment, causing short-term pressure on the stock.

Despite the market’s reaction, the company’s strategic progress and ongoing financial improvement continue to make it a key player in the global agrochemical space.

The Upcoming IPOs in this week and coming weeks are Integrity Belrise Industries, Integrity Infrabuild Developers, Accretion Pharmaceuticals, Wagons Learning.

The Current active IPO are Virtual Galaxy Infotech.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.